Figure 1 (IMAGE)

Impact Journals LLC

Figure 1

Caption

Figure 1: Response to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy.

Credit

2023 Assi et al.

Usage Restrictions

Original Content

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.